Cue Biopharma Inc. (CUE) Live Share Price, Invest From India

Cue Biopharma Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's Low
Day's High
$24.62
Day's Price Range
$26.75
$25.39
3.03%
Downside
5.36%
Upside
52 Week's Low
52 Week's High
$4.97
52-Week Price Range
$41.42
$25.39
80.42%
Downside
63.14%
Upside

Cue Biopharma Inc. share price movements today

Previous Close: $25.54
Open: $25.76
Volume: 333.0K
Day's Low - High: $24.62 - $26.75
52 Week Low - High: $4.97 - $41.42

Cue Biopharma Inc. Historical Returns

1 Month Return: + 27.51 %
3 Month Return: + 239.31 %
1 Year Return: + 7.85 %
3 Year Return: -77.05 %
5 Year Return: -93.68 %

Cue Biopharma Inc. Stock Fundamentals & Key Indicators

Check Cue Biopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$109.3M

EPS (TTM)

-6.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-18.2M

Revenue (TTM)

32.7M

Profit Margin

-59.65%

Return On Equity TTM

-138.52%

Cue Biopharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cue Biopharma Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cue Biopharma Inc.	BUY	$109.3M	-93.68%	NA	-59.65%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Cue Biopharma Inc. Stock including INR - Dollar returns

The Cue Biopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cue Biopharma Inc. investment value today

Current value as on today

₹1,18,064

Returns

₹18,064

(+18.06%)

Returns from Cue Biopharma Inc. Stock

₹7,221 (+7.22%)

Dollar Impact

₹10,842 (+10.84%)

Analyst Recommendation on Cue Biopharma Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Cue Biopharma Inc.. Average target price of $115

Cue Biopharma Inc. Share Price Target

Get share price movements and forecasts by analysts on Cue Biopharma Inc..

What analysts predicted

77.92%UPSIDE

Target Price

$115

Current Price

$25.39

Analyzed by

9 Analysts

Target

$115.00

Cue Biopharma Inc. target price $115, a slight upside of 77.92% compared to current price of $25.39. According to 9 analysts rating.

Indian Investors' Interest in Cue Biopharma Inc. Stock

Search interest for Cue Biopharma Inc. Stock has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:-81% versus previous 30 day period

Cue Biopharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	1	1	2	3	1	0	2	2	21	5
Gross Profit	-11	1	2	3	1	0	2	2	21	5
Operating Income	-13	-12	-10	-8	-9	-12	-8	-7	1	-5
EBITDA	-13	-11	-9	-7	-9	-11	-7	-7	3	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	1	0
Income Before Tax	-13	-12	-10	-8	-9	-12	-8	-7	2	-5
Income Tax Expense	0	0	-	-8	-	-	-	-	0	-
Net Income	-13	-12	-10	-8	-9	-12	-8	-7	1	-5
Net Profit Margin	-737.73%	-719.10%	-382.66%	-259.59%	-602.54%	-2911.40%	-287.14%	-346.58%	7.22%	-91.07%

Cue Biopharma Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	1	3	3	14	1	5	9	27
Gross Profit	0	0	-27	3	-30	14	1	-32	9	27
Operating Income	-7	-23	-38	-36	-45	-43	-53	-52	-41	-26
EBITDA	-7	-22	-37	-31	-43	-45	-50	-46	-37	-22
Interest Expense	-	-	-	5	0	1	0	1	0	0
Depreciation	-	0	0	5	1	-1	1	3	2	3
Income Before Tax	-7	-23	-38	-36	-44	-43	-53	-50	-40	-26
Income Tax Expense	-	-	0	0	0	0	0	3	-40	0
Net Income	-7	-23	-38	-36	-44	-44	-53	-50	-40	-26
Net Profit Margin	0.00%	0.00%	-3411.53%	-1061.25%	-1419.79%	-295.56%	-4257.83%	-924.10%	-437.97%	-96.85%

Cue Biopharma Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-12	-10	-8	-9	-12	-8	-7	1	-5
Operating Cash Flow	-9	-9	-7	-9	-8	-3	-9	-1	-10
Investing Cash Flow	0	0	0	0	0	0	-6	7	0
Financing Cash Flow	2	-1	9	0	-1	17	0	9	0
Change in Cash	-7	-11	2	-9	-9	14	-15	15	-10

Cue Biopharma Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-23	-38	-36	-44	-44	-53	-50	-40	-26
Operating Cash Flow	-12	-26	-30	-32	-38	-41	-39	-36	-21
Investing Cash Flow	-1	-20	3	4	9	-24	25	0	0
Financing Cash Flow	62	4	50	58	19	53	11	10	26
Change in Cash	48	-42	23	30	-10	-12	-3	-26	4

Global Institutional Holdings in Cue Biopharma Inc.

Funds	Holdings
ANGELES WEALTH MANAGEMENT, LLC	0.26%
Stifel Financial Corp	0.2%
Diadema Partners LP	0.11%
BOOTHBAY FUND MANAGEMENT, LLC	0.72%
Northern Trust Corp	0.08%

See all

Insights on Cue Biopharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CUE stock has moved up by 253.5%
NO EFFECT
Against Peers
In the last 3 years, Cue Biopharma, Inc. Common Stock has experienced a drawdown of -76.7%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 65.1%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 7.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 21.94M → 5.68M (in $), with an average decrease of 74.1% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.58M → -5.17M (in $), with an average decrease of 426.7% per quarter

About Cue Biopharma Inc.

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Organisation	Cue Biopharma Inc.
Headquarters	40 Guest Street, Boston, MA, United States, 02135
Industry	Biotechnology
CEO	Dr. Shao-Lee Lin M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Cue Biopharma Inc.

Name	Title
Dr. Steven C. Almo Ph.D.	Co-Founder and Chairman of Scientific & Clinical Advisory Board
Ms. Sumita Ray J.D.	Chief Legal & Compliance Officer and Corporate Secretary
Dr. Daniel G. Baker M.D., Ph.D.	Interim Chief Development Officer
Ms. Lucinda Warren	Principal Fin & Accounting Off. and Chief Financial & Business Officer
Mr. Colin G. Sandercock J.D., MSE	Senior Vice President of Intellectual Property
Dr. Shao-Lee Lin M.D., Ph.D.	President, CEO & Director
Dr. Ronald D. Seidel III, Ph.D.	Co-Founder
Dr. Rodolfo Jose Chaparro Ph.D.	Co-Founder

FAQs

What is Cue Biopharma Inc. share price today?

Cue Biopharma Inc. share price today is $25.39 as on June 27, 2026 at 8:46 am IST at the close of the market. Cue Biopharma Inc. share today touched a day high of $26.75 and a low of $24.62.

What is the 52 week high and 52 week low for Cue Biopharma Inc. share?

Cue Biopharma Inc. share touched a 52 week high of $41.42 on May 6, 2026 and a 52 week low of $4.97 on April 6, 2026. Cue Biopharma Inc. stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $25.39,which is 38.70% down from its 52 week high and 410.76% up from its 52 week low.

What is Cue Biopharma Inc.'s market capitalisation today?

Cue Biopharma Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in Cue Biopharma Inc. Stock (CUE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cue Biopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cue Biopharma Inc. Shares that will get you 0.0591 shares as per Cue Biopharma Inc. share price of $25.39 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cue Biopharma Inc. Stock (CUE) from India?

Indian investors can start investing in Cue Biopharma Inc. (CUE) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Cue Biopharma Inc. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:41 am IST). Based on Cue Biopharma Inc. share’s latest price of $25.39 as on June 27, 2026 at 8:46 am IST, you will get 0.3939 shares of Cue Biopharma Inc.. Learn more about fractional shares .

What are the returns that Cue Biopharma Inc. has given to Indian investors in the last 5 years?

Cue Biopharma Inc. stock has given -93.68% share price returns and 27.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?